Recombinant Mycoplasma pneumoniae Uncharacterized protein MPN_463 (MPN_463)

Shipped with Ice Packs
In Stock

Description

Overview of Uncharacterized Proteins in M. pneumoniae

Uncharacterized proteins in M. pneumoniae are hypothetical or poorly studied gene products with undetermined biological roles. These proteins are often prioritized for recombinant expression to explore their functions, interactions, or therapeutic potential . For example:

  • MPN_163: A homolog of MG149.1, recombinantly expressed in E. coli with a His tag .

  • MPN_465: Another uncharacterized protein produced recombinantly, with sequence and storage details documented .

Recombinant Protein Production Workflow

Recombinant proteins like MPN_163 or MPN_465 are typically generated using standardized protocols :

ParameterDetails
Expression SystemEscherichia coli (common for cost-effectiveness and scalability) .
TagHis tag for purification (e.g., MPN_163, MPN_465) .
Purity>90% (verified via SDS-PAGE) .
StorageLyophilized powder at -20°C/-80°C; Tris/PBS-based buffers .

Functional Insights from Analogous Proteins

While MPN_463 is not explicitly studied in the provided materials, insights can be drawn from similar proteins:

  • MPN_372: Binds human surfactant protein A (hSP-A), aiding respiratory colonization .

  • MPN_163: A substrate of the Lon protease, involved in protein quality control and complex assembly .

  • MPN_465: Contains repetitive sequences linked to antigenic variation and immune evasion .

Research Gaps and Future Directions

The absence of MPN_463-specific data highlights opportunities for further investigation:

  1. Genomic Context: MPN_463 may reside near recombination hotspots (e.g., MPN366–MPN371) .

  2. Functional Studies: Recombinant MPN_463 could clarify its role in adhesion, immune evasion, or metabolic pathways .

  3. Clinical Relevance: Potential as a diagnostic antigen or vaccine candidate if surface-exposed .

Technical Challenges in Characterizing Hypothetical Proteins

  • Low Expression: Many uncharacterized proteins are expressed at undetectable levels in native M. pneumoniae .

  • Structural Complexity: Membrane-associated proteins require advanced solubilization techniques .

  • Antigenic Variation: Repetitive sequences (e.g., RepMP) complicate recombinant production and functional assays .

Key Recommendations for Researchers

  1. Sequence Analysis: Verify MPN_463’s homology to known virulence factors (e.g., S1-like toxin domains in MPN_372) .

  2. Proteomic Profiling: Use conditional protease mutants (e.g., Lon/FtsH-depleted strains) to identify MPN_463 stability .

  3. Structural Studies: Employ cryo-EM or X-ray crystallography to resolve tertiary structures .

Final Remarks

The lack of direct data on recombinant MPN_463 underscores the need for targeted studies. Researchers should leverage existing frameworks for homologous proteins (e.g., MPN_163, MPN_465) to design expression systems and functional assays. Collaborative efforts combining genomics, proteomics, and immunology will be critical to unraveling this protein’s role in M. pneumoniae biology.

Product Specs

Form
Lyophilized powder. We will ship the available format, but please specify any format requirements when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. Proteins are shipped with blue ice packs. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. Specify your preferred tag type, and we will prioritize its development.
Synonyms
MPN_463; H08_orf157a; MP378; Uncharacterized protein MPN_463
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-157
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycoplasma pneumoniae (strain ATCC 29342 / M129)
Target Names
MPN_463
Target Protein Sequence
MGGWMSCAPP IYTPHTNSWT ESGWDRTSWW RWSAQRWSGW SFKIVRANKA LRVMAKTKMP LVLIPPSPNK PYSKLAINQE LHLTPHKKTS PATSSSLKPR PGPRGYLNAR LSWRCPTLSR KVRVPTIKVP MVRAPSTKPS KTSSSNNPWP LTPRMRG
Uniprot No.

Q&A

What are the most effective methods for initial identification of MPN_463 in Mycoplasma pneumoniae?

Initial identification of uncharacterized proteins like MPN_463 typically employs a multi-stage approach. The most effective methodology involves construction of in vitro gene fusions between a modified reporter gene (such as mouse dehydrofolate reductase) and selected regions of the M. pneumoniae genome, followed by expression in host systems like Escherichia coli. Positive clones can be identified using antibodies against specific fractions of M. pneumoniae, allowing for subsequent sequence analysis and comparison against protein databanks for potential homologies .

For MPN_463 specifically, researchers should consider:

  • Genomic library construction from M. pneumoniae

  • PCR amplification of the specific MPN_463 coding region

  • Cloning into appropriate expression vectors

  • Protein expression in bacterial systems

  • Confirmation via Western blotting with specific antibodies

How can I determine the size and subcellular location of MPN_463?

Determining the size and subcellular location of MPN_463 requires a methodical approach using both biochemical and immunological techniques. Size determination is typically achieved through SDS-PAGE analysis of M. pneumoniae cell extracts followed by Western blotting using monospecific antibodies generated against fusion proteins containing MPN_463 . For subcellular localization, immunoscreening of different cellular fractions (membrane, cytosolic, and peripheral membrane proteins) can reveal the distribution pattern of MPN_463 within the bacterial cell.

A comprehensive approach should include:

  • Generation of monospecific antibodies against purified recombinant MPN_463

  • Fractionation of M. pneumoniae cells into membrane, cytosolic, and other compartments

  • SDS-PAGE separation of proteins from each fraction

  • Western blot analysis using anti-MPN_463 antibodies

  • Immunofluorescence microscopy on intact cells for visual confirmation

What expression systems are most suitable for producing recombinant MPN_463?

Expression SystemAdvantagesLimitationsRecommended for MPN_463
E. coliHigh yield, easy manipulation, economicalLimited post-translational modificationsInitial characterization studies
Yeast systemsBetter folding, some post-translational modificationsLonger production timeIf E. coli yields inactive protein
Mammalian cellsNative-like modificationsExpensive, low yieldAdvanced functional studies
Cell-free systemsRapid, avoids toxicity issuesExpensive, lower yieldPreliminary functional assays

For optimal expression of MPN_463, consider starting with multiple E. coli strains (BL21, Rosetta, Arctic Express) to identify conditions yielding soluble protein.

What purification challenges are specific to MPN_463, and how can they be overcome?

Purification of uncharacterized proteins like MPN_463 presents several challenges, particularly regarding solubility and stability. Without detailed knowledge of the protein's properties, a systematic approach is necessary.

Recommended purification strategy:

  • Start with affinity chromatography using polyhistidine or other fusion tags

  • Assess protein solubility in various buffers (pH range 6.0-8.0, NaCl concentration 150-500 mM)

  • Include stabilizing agents such as glycerol (10-20%) if necessary

  • Consider refolding protocols if the protein forms inclusion bodies

  • Verify purity using SDS-PAGE and functionality through appropriate activity assays

For membrane-associated proteins, detergent screening is crucial. Test a panel of detergents (CHAPS, DDM, Triton X-100) at various concentrations to optimize extraction while maintaining protein structure.

How can I determine the potential function of uncharacterized MPN_463?

Determining the function of uncharacterized proteins requires a multifaceted approach combining bioinformatic prediction with experimental validation. For MPN_463, consider these methodological approaches:

  • Bioinformatic analysis:

    • Sequence homology searches against characterized proteins

    • Structural prediction using tools like AlphaFold or I-TASSER

    • Identification of conserved domains or motifs

    • Genomic context analysis (operons, gene neighborhoods)

  • Experimental validation:

    • Protein interaction studies (pull-down assays, yeast two-hybrid)

    • Gene knockout/knockdown phenotype analysis

    • Localization studies to inform potential function

    • Functional complementation in model organisms

When dealing with contradictory results, prioritize direct experimental evidence over computational predictions and validate findings through multiple independent techniques.

What experimental design considerations are important when studying MPN_463 interactions with host cells?

When investigating potential interactions between MPN_463 and host cells, careful experimental design is essential for generating reliable and reproducible results. Key methodological considerations include:

  • Controls selection:

    • Positive controls using known M. pneumoniae virulence factors

    • Negative controls with unrelated recombinant proteins

    • Mock treatments to control for buffer effects

  • Cell type selection:

    • Primary human respiratory epithelial cells for physiological relevance

    • Standardized cell lines for consistency and reproducibility

    • Multiple cell types to distinguish tissue-specific effects

  • Quantification methods:

    • Clear definition of dependent and independent variables

    • Appropriate statistical approaches for data analysis

    • Blinding and randomization to minimize bias

  • Sample size determination:

    • Power analysis to determine appropriate replicate numbers

    • Account for experimental variability

    • Plan for both biological and technical replicates

How should I analyze conflicting results when characterizing MPN_463?

When encountering conflicting results during MPN_463 characterization, apply a systematic approach:

  • Methodological validation:

    • Review experimental protocols for differences in methods

    • Assess reagent quality and specificity

    • Consider biological variability in different strains or isolates

  • Statistical reassessment:

    • Evaluate statistical power of conflicting studies

    • Consider applying more robust statistical methods

    • Conduct meta-analysis when multiple datasets are available

  • Resolution strategies:

    • Design experiments that directly address discrepancies

    • Employ orthogonal techniques to validate findings

    • Collaborate with laboratories reporting conflicting results

Remember that contradictory results often lead to deeper understanding of complex biological systems and may reflect genuine biological variability or context-dependent protein functions.

What are the best approaches for studying potential post-translational modifications of MPN_463?

Despite Mycoplasma having a reduced genome, post-translational modifications (PTMs) still play important roles in protein function. For MPN_463, consider these methodological approaches:

  • Mass spectrometry analysis:

    • Perform tryptic digestion of purified MPN_463

    • Use high-resolution LC-MS/MS for PTM identification

    • Consider enrichment strategies for specific modifications

  • Site-directed mutagenesis:

    • Mutate predicted modification sites

    • Compare function of wild-type vs. mutant proteins

    • Assess stability and localization changes

  • Specific PTM detection:

    • Phosphorylation: Pro-Q Diamond staining, phospho-specific antibodies

    • Glycosylation: Lectin binding assays, glycan-specific staining

    • Lipidation: Metabolic labeling with fatty acid analogs

A comprehensive PTM characterization requires combining computational prediction with direct experimental evidence using multiple complementary techniques.

How should I design experiments to test hypotheses about MPN_463 function?

Rigorous experimental design is critical when testing hypotheses about uncharacterized proteins like MPN_463. Follow these methodological guidelines:

  • Hypothesis formulation:

    • Develop specific, testable hypotheses based on preliminary data

    • Consider alternative hypotheses that could explain observations

    • Frame hypotheses in the context of M. pneumoniae biology

  • Experimental approach:

    • Design experiments with appropriate positive and negative controls

    • Include technical and biological replicates

    • Implement blinding and randomization where possible

    • Consider both gain-of-function and loss-of-function approaches

  • Controls and variables:

    • Clearly define dependent and independent variables

    • Control for confounding factors

    • Use appropriate statistical methods for data analysis

  • Validation strategy:

    • Plan for validation using orthogonal methods

    • Consider how to address potential conflicting results

    • Design follow-up experiments based on possible outcomes

What are the key considerations for designing knockout or knockdown studies of MPN_463?

Genetic manipulation studies provide powerful insights into protein function. For MPN_463, consider these methodological approaches:

  • Knockout strategy selection:

    • CRISPR-Cas9 systems adapted for Mycoplasma

    • Homologous recombination approaches

    • Transposon mutagenesis screening

  • Phenotype assessment plan:

    • Growth curve analysis under various conditions

    • Microscopy for morphological changes

    • Virulence/colonization assays in model systems

    • Transcriptomic/proteomic profiling of mutants

  • Complementation studies:

    • Reintroduction of wild-type MPN_463

    • Testing of mutant variants

    • Use of inducible expression systems

  • Controls:

    • Empty vector controls

    • Unrelated gene knockout controls

    • Wild-type strain comparisons

How can I effectively collaborate with other researchers studying M. pneumoniae proteins?

Effective collaboration enhances research quality and accelerates discovery. For MPN_463 research, consider:

  • Resource sharing:

    • Contribute to public repositories (GenBank, PDB) promptly

    • Document methodologies thoroughly in publications

    • Share reagents (plasmids, antibodies) through repositories

  • Experimental standardization:

    • Adopt common protocols and reporting standards

    • Use consistent cell lines and bacterial strains

    • Implement rigorous experimental design practices

  • Data integration approaches:

    • Combine diverse datasets (genomic, proteomic, functional)

    • Utilize standard data formats for computational analysis

    • Implement reproducible computational workflows

Collaborative research on uncharacterized proteins benefits from complementary expertise and methodologies, ultimately accelerating functional characterization.

What statistical approaches are most appropriate for MPN_463 functional studies?

  • Experimental design statistics:

    • A priori power analysis to determine sample size

    • Randomization schemes to minimize bias

    • Factorial designs to assess multiple variables efficiently

  • Data analysis approaches:

    • Select appropriate tests based on data distribution (parametric vs. non-parametric)

    • Account for multiple comparisons when necessary

    • Consider mixed-effects models for complex experimental designs

  • Advanced analytical methods:

    • Consider Bayesian approaches for complex datasets

    • Use multivariate statistics for high-dimensional data

    • Implement machine learning for pattern recognition in large datasets

  • Reporting standards:

    • Report effect sizes in addition to p-values

    • Provide complete statistical details for reproducibility

    • Consider publishing raw data alongside analyses

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.